News Conference News ESC 2022 DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark L.A. McKeown August 30, 2022
News Conference News ESC 2022 Less Death, Major Bleeding With Transradial Access: Meta-analysis Michael O'Riordan August 29, 2022
News Conference News ESC 2022 P2Y12 Inhibitors Top Aspirin for Long-term Secondary Prevention: PANTHER Todd Neale August 29, 2022
News Conference News ESC 2022 ‘Hot’ Plaque on Noninvasive PET May Presage MI, CV Death: PRE18FFIR Shelley Wood August 28, 2022
News Conference News ESC 2022 Factor XIa Inhibitors Show Potential for Safer Anticoagulation After MI, Stroke Todd Neale August 28, 2022
News Conference News ESC 2022 Polypill Bests Usual Care in Patients With Recent MI: SECURE Michael O'Riordan August 26, 2022
News Daily News Genetic Study Hints at Cognitive Impact of Statins, but Experts Urge Caution Michael O'Riordan August 11, 2022
News Daily News Acute MI, Stroke Risks Rise in the Months After Gout Flares Todd Neale August 02, 2022
News Daily News Longer-Term Data Still Worrisome for Impella-Treated AMICS Patients Caitlin E. Cox July 20, 2022
News Daily News Early Redo TAVI Outcomes Look Good, but ‘Far From Definitive’ Michael O'Riordan July 18, 2022
News Daily News Respiratory Issues Dominate NACMI Risk Score for COVID/STEMI Mortality L.A. McKeown July 13, 2022
News Daily News ‘Code Blue’ for the Dire CVD Health Status of Most US Adults Michael O'Riordan July 05, 2022
News Daily News Following Takotsubo, Men Have Worse Outcomes, Are More Likely to Die Than Women Yael L. Maxwell June 03, 2022
News Conference News SCAI 2022 Cath Labs Trying to Get Back on Track With Quality Measures, Documentation L.A. McKeown May 27, 2022
News Conference News SCAI 2022 Cocaine History? For Black Patients It Means Less Chance of Revascularization L.A. McKeown May 26, 2022
News Conference News EAS 2022 FH Patients Face Unchanging Acute MI Risks Plus Very Late Diagnoses Michael O'Riordan May 26, 2022
News Conference News EAS 2022 Lp(a) Linked to ASCVD and Aortic Stenosis Regardless of CRP Level Michael O'Riordan May 24, 2022
News Conference News EAS 2022 ROSE Trial: CETP Inhibitor Shows Promise as Oral Add-on for LDL-Lowering Michael O'Riordan May 24, 2022